Our Laboratory
LGC, the globally recognized testing laboratory behind Informed Manufacturer, is a world-renowned sports doping control and research laboratory, with over 60 years of experience of regulatory analysis in quality supplement manufacturing. With over 400 published scientific papers and over 500 person-years of research into doping control, LGC is recognised as a global leader and trusted partner in the field of anti-doping and dietary supplement analysis. As a leading ingredient analysis laboratory, LGC supports manufacturing certification through advanced contamination screening and scientific research. Brands can also review Informed Manufacturer’s certified manufacturers to verify participating companies and facility details.
CERTIFY YOUR MANUFACTURING SITE TODAY!
This page explains how INFORMED conducts manufacturing testing, what substances are screened, and how our laboratory supports quality certification for manufacturing facilities worldwide.
What Is Manufacturing Testing?
Manufacturing testing refers to the screening and analysis of facilities, swab samples, and production environments to detect contamination risks before products reach the market. Informed Manufacturer’s manufacturing testing facility through LGC evaluates critical control points to reduce banned substance contamination and support safe supplement production.
LGC has been conducting manufacturing testing of supplements, ingredients and manufacturing sites for more than 15 years. During this time, more than 225,000 samples have been tested and a number of research studies have been conducted; such as studies exploring the prevalence of prohibited substance contamination within supplement products.
To understand the risks elite athletes face, LGC conducts administration studies which have been published in peer-reviewed scientific journals. These studies have highlighted that consuming even microgram quantities of a prohibited substance (millionths of a gram) could give rise to a positive doping violation. LGC has also published white papers highlighting research on supplement contamination.
The field of anti-doping is continually changing, with new and emerging threats/risks continuing to challenge the supplement industry and the anti-doping community. To address these challenges, LGC is continuously developing and evolving screening methodology, with ongoing method development and research programmes conducted by our specialist laboratory. To provide assurance to brands and consumers alike, LGC routinely screens facilities and products for more than 300 compounds that are prohibited in sports and/or are potentially harmful to health as part of its manufacturing testing programme, supporting facilities seeking quality certification for manufacturing. This includes drugs of abuse, anabolic agents, stimulants, beta-2 agonists, diuretics and new and emerging threats.
As a doping control laboratory, LGC works directly with sports authorities, national anti-doping organisations and national governing bodies worldwide. Providing advice and expert support, LGC is able to represent the views of partners and assist in the shaping of future regulation.
What Does the Manufacturing Testing Facility Screen For?
Testing Specifications
LGC has shaped its screening programme by conducting surveillance analysis and research to assess contamination risks within manufacturing testing facilities. LGC works closely with a number of key stakeholders within the anti-doping community and supplement industry, to ensure that quality certification for manufacturing sites remains at the forefront of risk management. Informed Manufacturer works alongside leading supplement testing companies to ensure industry standards remain rigorous and aligned with evolving anti-doping requirements.
Download Our Detection of Synthetic Pharmaceutical Compounds White Paper
LGC currently tests over 25,000 samples each year for more than 300 compounds that are prohibited in sports and/or are potentially harmful to health. Screening includes, but is not limited to, testing for compounds such as anabolic agents, stimulants, narcotics, beta-2 agonists, diuretics and new and evolving threats such as vaptans and PPAR's etc.
|
LGC is continuously reviewing and developing its testing methodology to ensure new and emerging threats within the manufacturing supplements industry are addressed - this often includes the surveillance and investigation of suspicious compounds before their prohibited status is confirmed by the wider anti-doping community.